Academic Journal
Q1Circulation Journal
About Circulation Journal
About Circulation Journal
Circulation Journal is a peer-reviewed scholarly journal published by Japanese Circulation Society (Japan). It focuses on Q1. Publication coverage spans 1996, 1999-2000, 2002-2026.
Key indicators: ISSN 1347-4820, 1346-9843; H-index 132.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (132): Exceptionally high — 132 articles have each been cited at least 132 times. This indicates deep, sustained influence in the field.
Publishing in Circulation Journal
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Circulation Journal?
1347-4820, 1346-9843.
Who publishes Circulation Journal?
Japanese Circulation Society.
What are Circulation Journal's metrics?
H-index 132.
Is Circulation Journal peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Cardiovascular Function and Risk Factors; Cardiac Imaging and Diagnostics; Atrial Fibrillation Management and Outcomes; Coronary Interventions and Diagnostics; Cardiac electrophysiology and arrhythmias; Cardiac Arrhythmias and Treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Nationwide Evolution of Durable Left Ventricular Assist Device Outcomes Following Introduction of the HeartMate 3 and Destination Therapy in Japan ― The Third Official Report From J-MACS ―
Teruhiko Imamura, Koichiro Kinugawa, Takashi Nishimura, Koichi Toda et al.
2026-10-14 · DOI: 10.1253/circj.cj-26-0575Phenotyping Heart Failure With Preserved Ejection Fraction in Japan ― Position Paper on Current Evidence and Future Directions ―
Yasushi Sakata, Yuki Matsuoka, Kotaro Nochioka, Atsushi Kyodo et al.
2026-10-10 · DOI: 10.1253/circj.cj-26-0356Prognostic Impact of Left Ventricular Apical Aneurysm Identified by Echocardiography in Hypertrophic Cardiomyopathy ― A Multicenter Retrospective Study in Japan ―
Junya Komatsu, Naoki Arima, Yuri Ochi, Toru Kubo et al.
2026-10-06 · DOI: 10.1253/circj.cj-26-0311Risk Stratification for Pericardial Effusion After Leadless Pacemaker Implantation ― Multicenter Study ―
Yuya Komai, Hitoshi Minamiguchi, Masayuki Ishimura, Yuichiro Sakamoto et al.
2026-10-03 · DOI: 10.1253/circj.cj-25-1061In-Hospital Guideline-Directed Medical Therapy Intensification and Long-Term Outcomes in Patients Hospitalized for Heart Failure in the Current Clinical Paradigm ― Insights From the QHEART-R Study ―
Toru Hashimoto, Ryuichi Matsukawa, Shouji Matsushima, Kayo Misumi et al.
2026-10-03 · DOI: 10.1253/circj.cj-26-0697Comprehensive Cardiac Computed Tomography for Anatomical Assessment, Functional Analysis, and Myocardial Tissue Characterization in a Patient With Coronary Anomaly and Cardiac Amyloidosis
Hiroyuki Takaoka, Noriko Suzuki-Eguchi, Ken Kato, Yoshitada Noguchi et al.
2026-10-02 · DOI: 10.1253/circj.cj-26-0803Multiple Calcified Nodules Associated With 3 Temporally Distinct Myocardial Infarctions
Chiharu Nishino, Shun Nishino, Nehiro Kuriyama, Yoshisato Shibata et al.
2026-10-02 · DOI: 10.1253/circj.cj-26-0813Serial 4-Dimensional Flow Cardiac Magnetic Resonance Imaging Visualizes Incremental Hemodynamic Improvement Following Alcohol Septal Ablation and Subsequent Mavacamten Therapy
Keitaro Akita, Kenichiro Suwa, Yuichiro Maekawa
2026-09-30 · DOI: 10.1253/circj.cj-26-0757When Earlier Is Better But Still Not Cost-Effective ― Reframing the Value of Tafamidis in Transthyretin Amyloid Cardiomyopathy ―
Takuya Kishi
2026-09-30 · DOI: 10.1253/circj.cj-26-0898Platelet–Albumin–Bilirubin Index for Predicting Hospitalization and Mortality in Pulmonary Hypertension
Mehmet A. Gelen, Görkem Yıldız, Hasan A. Bolayır, Mehdi Karasu et al.
2026-09-30 · DOI: 10.1253/circj.cj-26-0436Surgical Repair of Right Ventricular Free Wall Blow-Out Rupture
Masayuki Nishiyama, Takayuki Okada, Takashi Nishimura, Kei Tanaka et al.
2026-09-30 · DOI: 10.1253/circj.cj-26-0741Stage-Specific Cost-Effectiveness of Early vs. Delayed Tafamidis for Transthyretin Amyloid Cardiomyopathy in Japan
Yasufumi Nagata, Yosuke Nabeshima, Tetsuji Kitano, Masaaki Takeuchi et al.
2026-09-29 · DOI: 10.1253/circj.cj-26-0576Cardiovascular–Kidney–Metabolic Syndrome Age Derived From Routine Health Checkup and Claims Data ― Large-Scale Epidemiological Study ―
Yuta Suzuki, Hidehiro Kaneko, Masachika Nishikawa, Akira Okada et al.
2026-09-25 · DOI: 10.1253/circj.cj-26-0498Renal Denervation for Hypertension ― Mechanisms, Evidence, and Clinical Integration ―
Takanori Sato, Yuichi Saito, Jiro Aoki, Eiichiro Yamamoto et al.
2026-09-25 · DOI: 10.1253/circj.cj-25-1042Epidemiology of Cardiovascular Disease in Pregnancy in Japan ― Analysis of a Nationwide Perinatal Database 2014–2023 ―
Masafumi Nii, Shoko Chishaki-Kawabata, Koshiro Kanaoka, Shinji Katsuragi et al.
2026-09-25 · DOI: 10.1253/circj.cj-26-0154Targeting Nuclear Factor-κB1 With Andrographolide ― Novel Strategy to Inhibit Vascular Lesions and Aneurysm Formation in Abdominal Aortic Aneurysm ―
Ying Wen, Xing Fu, Zheng Chen, Jianxiang Wang et al.
2026-09-25 · DOI: 10.1253/circj.cj-25-0709Association Between Changes in Serum N-Terminal Pro B-Type Natriuretic Peptide Levels and All-Cause and Cause-Specific Mortality ― The Hisayama Study ―
Asahi Kato, Emi Oishi, Akihiro Maezono, Satoko Sakata et al.
2026-09-25 · DOI: 10.1253/circj.cj-25-1168Estimated Small Dense Low-Density Lipoprotein Cholesterol Is Independently Associated With Arterial Stiffness ― Large Japanese Screening Study ―
Shuya Shinchi, Yuichi Akasaki, Daisuke Tokutake, Shin Kawasoe et al.
2026-09-25 · DOI: 10.1253/circj.cj-26-0093Defining Sarcopenic Obesity in the Asian Working Group for Sarcopenia 2025 Era: Diagnostic Precision Matters
Yoshihiro Yoshimura, Ayaka Matsumoto
2026-09-25 · DOI: 10.1253/circj.cj-26-0902Low Body Weight and Long-Term Outcomes in Cancer-Associated Venous Thromboembolism ― From the COMMAND VTE Registry-2 ―
Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto et al.
2026-09-25 · DOI: 10.1253/circj.cj-26-0325Reviews
Community Reviews
Version History
October 9, 2026 at 7:51 pm
September 25, 2026